Table 1.
Prevalence studies on primary Sjögren’s syndrome in Europe according to the AECG criteria
| Author | Publication year | Country | Population size | Criteria | Prevalence % |
|---|---|---|---|---|---|
| (95 % CI) | |||||
| Trontzas & Andrianakos [15] | 2005 | Greece | 8740 | AECG | 0.15 (0.09–0.21) |
| Alamanos et al. [11] | 2006 | Greece | 488,435 | AECG | 0.09 (0.08–0.1)b |
| Kabasakal et al. [14] | 2006 | Turkey | 831 | AECG | 0.72 (0.33–1.57)a |
| Birlik et al. [97] | 2009 | Turkey | 2835 | AECG | 0.21 (0.03–0.29) |
| Anagnostopoulos et al. [98] | 2010 | Greece | 3528 | AECG | 0.23 (0.22–0.75) |
| Göransson et al. [12•] | 2011 | Norway | 852,342 | AECG | 0.05 (0.048–0.052)b |
| Maldini et al. [13•] | 2014 | France | 1,172,482 | AECG | 0.01 (0.01–0.02)b |
aThe prevalence of pSS in the study of Kabasakal et al. was based on a female population only
bPopulation-based studies conducted on a large background population